Welcome to LookChem.com Sign In|Join Free
  • or
(±)-2-(4-fluorophenyl)-3-phenylpropanoic acid is a chiral organic compound with the molecular formula C15H13FO2. It features a 3-phenylpropanoic acid backbone, with a 4-fluorophenyl group attached at the 2-position and a phenyl group at the 3-position. (±)-2-(4-fluorophenyl)-3-phenylpropanoic acid is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals, particularly as a building block for the development of chiral molecules. Its chemical structure allows for the exploration of stereochemistry in drug design, as the presence of a chiral center can lead to different biological activities depending on the configuration of the molecule. The compound's properties, such as its acidity and lipophilicity, can be manipulated to optimize its interaction with biological targets, making it a valuable intermediate in the creation of new therapeutic agents.

1086-76-6

Post Buying Request

1086-76-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1086-76-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1086-76-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,8 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1086-76:
(6*1)+(5*0)+(4*8)+(3*6)+(2*7)+(1*6)=76
76 % 10 = 6
So 1086-76-6 is a valid CAS Registry Number.

1086-76-6Relevant academic research and scientific papers

GUANIDINE DERIVATIVES AS TRPC MODULATORS

-

Page/Page column 43; 49, (2014/02/16)

The present invention is directed to guanidine derivatives as inhibitors of transient receptor potential canonical channels (TRPC channels), in particular TRPC3 and/or TRPC6 and/or TRPC7 activity, more particularly TRPC6 activity. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders mediated by TRPC channels (Formula (I))

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1086-76-6